Evidence map›Paper›PMID 24625781›Full record

ArticleNature protocols2014

Quantitative analysis of ribonucleoside modifications in tRNA by HPLC-coupled mass spectrometry.

Dan Su, Clement T Y Chan, Chen Gu, Kok Seong Lim, Yok Hian Chionh, Megan E McBee, Brandon S Russell, I Ramesh Babu, Thomas J Begley, Peter C Dedon

Abstract read
In one paragraph

Article in Nature protocols, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 189 papers.

0numbers the graph read from it
0cells of the map it votes in
189citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

189 citing papers in PubMed, 292 citations in OpenAlex.

  1. Detection and sequencing of ApProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. NNature plants · 2026
    Article
  6. Article
  7. Article
  8. tRNA modifications in viral replication.The Journal of biological chemistry · 2026
    Review
  9. Review
  10. RNA modifications in cancer and their detection: a review.Japanese journal of clinical oncology · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

129 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Dan Su1] Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, USA. [2].
Clement T Y Chan1] Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, USA. [2].
Chen GuDepartment of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, USA.
Kok Seong Lim1] Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, USA. [2].
Yok Hian ChionhSingapore-MIT Alliance for Research and Technology, Campus for Research Excellence and Technical Enterprise (CREATE), Singapore.
Megan E McBeeSingapore-MIT Alliance for Research and Technology, Campus for Research Excellence and Technical Enterprise (CREATE), Singapore.
Brandon S RussellDepartment of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, USA.
I Ramesh BabuDepartment of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, USA.
Thomas J BegleyCollege of Nanoscale Science and Engineering, University at Albany, State University of New York, Albany, New York, USA.
Peter C Dedon1] Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, USA. [2] Singapore-MIT Alliance for Research and Technology, Campus for Research Excellence and Technical Enterprise (CREATE), Singapore. [3] Center for Environmental Health Science, MIT, Cambridge, Massachusetts, USA.
Massachusetts Institute of Technology · USSingapore-MIT Alliance for Research and Technology · SGAlbany State University · US

Funding

TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI NILES, JACQUIN C · 1985 to 2020
$25.6M
The Roles of Trm9 and tRNA Methylation in the DNA Damage ResponseR01ES015037 · NIEHS · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI BEGLEY, THOMAS J · 2006 to 2010
$2.4M
RNA Modifications as Biomarkers of Environmental Stress and InflammationR01ES017010 · NIEHS · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI BEGLEY, THOMAS J · 2009 to 2013
$2.1M
Sulfur DNA modifications in gut microbes confer resistance to oxidative stressR21AI112711 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI DEDON, PETER C · 2014 to 2015
$429k
Quantitative analysis of damage to the nucleotide poolR21ES022858 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI DEDON, PETER C · 2014 to 2015
$429k
Howard Hughes Medical InstituteNIAID NIH HHS R21 AI112711NIEHS NIH HHS ES002109NIEHS NIH HHS ES015037NIEHS NIH HHS ES017010NIEHS NIH HHS P30 ES002109NIEHS NIH HHS R01 ES015037NIEHS NIH HHS R01 ES017010NIEHS NIH HHS R21 ES022858
6 · The paper itself

Abstract

Post-transcriptional modification of RNA is an important determinant of RNA quality control, translational efficiency, RNA-protein interactions and stress response. This is illustrated by the observation of toxicant-specific changes in the spectrum of tRNA modifications in a stress-response mechanism involving selective translation of codon-biased mRNA for crucial proteins. To facilitate systems-level studies of RNA modifications, we developed a liquid chromatography-mass spectrometry (LC-MS) technique for the quantitative analysis of modified ribonucleosides in tRNA. The protocol includes tRNA purification by HPLC, enzymatic hydrolysis, reversed-phase HPLC resolution of the ribonucleosides, and identification and quantification of individual ribonucleosides by LC-MS via dynamic multiple reaction monitoring (DMRM). In this approach, the relative proportions of modified ribonucleosides are quantified in several micrograms of tRNA in a 15-min LC-MS run. This protocol can be modified to analyze other types of RNA by modifying the steps for RNA purification as appropriate. By comparison, traditional methods for detecting modified ribonucleosides are labor- and time-intensive, they require larger RNA quantities, they are modification-specific or require radioactive labeling.

Indexed as

Chromatography, High Pressure LiquidMass SpectrometryRibonucleosidesRNA, TransferRibonucleosidesRNA, Transfer

Identifiers

PMID24625781
PMCPMC4313537
OpenAlexW2082617758

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.